novartis.com shows sustained decline with 3 consecutive months of decreases, down 45% overall to 1M.
Source: Autobound Signal API · 77 signals tracked for Novartis · updated
Get Novartis' live signals in Claude or ChatGPT, or by API
What changed at Novartis this week? Use Autobound signals for novartis.com.What happened
Emerging AI traffic at 1.1% (~11,689 visits). Top: chatgpt.com (78%), gemini.google.com (5%), claude.ai (3%).
Extracted by Autobound
From the Signal API record- Signal
- Sustained decline
What this signalsTraffic trends often track demand, marketing spend and growth.
- Monthly visits
- 1,021,295
- Month over month
- -22.6%
- 3-month change
- -44.7%
- Global rank
- 51,287
- Top country
- US (35%)
- Trend
- Consecutive decline
More from Novartis
- PatentsNOVARTIS AG's patent output is steady: 73 grants in the past year, 5 in the past 30 days.Patents
- Web trafficnovartis.com received 1M monthly visits with traffic from 5 countries.Web traffic
- In developmentNew long-term Rhapsido® (remibrutinib) Phase III data show sustained efficacy through week 52 in chronic inducible urticaria (CIndU)In development
- RecognitionNovartis ranks first place in 2026 Access to Medicine IndexRecognition
- GlassdoorInternal concerns regarding reactive strategy to competitor actions in the marketGlassdoor
- RedditNovartis confirmed nine reported cases of tumors linked to its spinal muscular atrophy gene therapy Zolgensma, with causality confirmed in two patients.Reddit
Latest signals at other companies
- Hacker NewsVercelShow HN: Vercel Board – a shared, secure message board for agents (public beta)Hacker News
- PatentsA. O. SmithA. O. Smith Corporation's patent output is slowing: 8 grants in the past year, 0 in the past 30 days.Patents
- PatentsAbbottAbbott Laboratories's patent output is accelerating: 12 grants in the past year, 2 in the past 30 days.Patents
The full record
From the Signal API recordNumbers
- Country rank
- 30,616
- Category rank
- 21
- Change, 3 months
- -44.7%
- Change, month over month
- -22.6%
- Digital health score
- 64
Details
- Measured month
- Aug 2026
- Category
- health/biotechnology_and_pharmaceuticals
- Mail visits
- 15,319
- Traffic band
- Established
- Direct visits
- 306,389
- Search visits
- 374,815
- Small website
- No
- Snapshot date
- Aug 1, 2026
- Social visits
- 171,578
- Website title
- Stay Up-to-Date
- Brand strength
- Moderate
- Referral visits
- 125,619
- AI traffic level
- Emerging
- AI traffic detail
- Emerging AI traffic at 1.1% (~11,689 visits). Top: chatgpt.com (78%), gemini.google.com (5%), claude.ai (3%).
- Geo concentration
- Moderately concentrated
- Consecutive months
- 3
- Brand keyword ratio
- 3/5
- Website description
- Sizi Novartis ve hastalar, aileler ve toplulukları üzerindeki etkimiz hakkında daha fazla bilgi edinmeye davet ediyoruz. Novartis, dünyanın her yerinde hastaların dönüşen ihtiyaçlarına çözümler üreten İsviçre merkezli global bir sağlık...
- Country rank country
- US
- Digital health label
- Good
- Social traffic level
- High
- Brand strength detail
- Moderate brand recognition with 30% direct traffic. Brand keyword ratio: 3/5.
- Digital health detail
- Score 64: Engagement 43/100 (25%), Volume 100/100 (20%), Brand 60/100 (15%), Diversification 80/100 (15%), Rank 75/100 (15%), AI Readiness 11/100 (10%).
- Social traffic detail
- High social traffic at 17% of total visits (~171,578 visits).
Extraction
- Detected
- Sep 11, 2026
- signal_type
seo-traffic- signal_subtype
sustainedDecline
Use this data
Get every website traffic signal for Novartis and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Novartis this week?”
Send it to your own tools
The Signal API returns website traffic signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full seo-traffic record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/83261b88-9998-4cd9-8cfa-6b404ebc1f45 returns this record as JSON. POST /v1/companies/enrich returns every signal for novartis.com.
{
"signal_id": "83261b88-9998-4cd9-8cfa-6b404ebc1f45",
"signal_type": "seo-traffic",
"signal_subtype": "sustainedDecline",
"detected_at": "2026-09-11T10:44:12.677+00:00",
"company": {
"name": "Novartis",
"domain": "novartis.com"
},
"data": {
"trend": "consecutive_decline",
"summary": "novartis.com shows sustained decline with 3 consecutive months of decreases, down 45% overall to 1M.",
"traffic": {
"2026-06-01": 1845458,
"2026-07-01": 1319655,
"2026-08-01": 1021295
},
"category": "health/biotechnology_and_pharmaceuticals",
"relevance": 63.3,
"ai_traffic": {
"total_visits": 11689,
"top_platforms": [
{
"name": "chatgpt.com",
"rank": 1,
"share": 77.921
},
{
"name": "gemini.google.com",
"rank": 2,
"share": 4.786
},
{
"name": "claude.ai",
"rank": 3,
"share": 3.065
}
],
"traffic_share": 0.011
},
"engagement": {
"bounce_rate": 0.496,
"pages_per_visit": 2.935,
"avg_visit_duration_seconds": 88
},
"global_rank": 51287,
"mail_visits": 15319,
"country_rank": 30616,
"top_keywords": [
{
"cpc": 3.01,
"name": "novartis",
"volume": 80090,
"estimated_value": 58020
},
{
"name": "نوفارتس",
"volume": 6380,
"estimated_value": 22250
},
{
"cpc": 1.08,
"name": "novartis careers",
"volume": 11190,
"estimated_value": 14320
},
{
"cpc": 0.85,
"name": "novartis jobs",
"volume": 3040,
"estimated_value": 4280
},
{
"cpc": 1.43,
"name": "ノバルティスファーマ",
"volume": 1820,
"estimated_value": 1700
}
],
"traffic_band": "established",
"category_rank": 21,
"direct_visits": 306389,
"search_visits": 374815,
"small_website": false,
"snapshot_date": "2026-08-01T00:00:00+00:00",
"social_visits": 171578,
"top_countries": {
"CH": 0.056,
"DE": 0.039,
"IN": 0.09,
"JP": 0.08,
"US": 0.345
},
"website_title": "Stay Up-to-Date",
"brand_strength": "moderate",
"change_3mo_pct": -44.7,
"change_mom_pct": -22.6,
"referral_visits": 125619,
"traffic_sources": {
"mail": 0.015,
"paid": 0,
"direct": 0.3,
"search": 0.367,
"social": 0.168,
"referral": 0.123
},
"ai_traffic_level": "emerging",
"ai_traffic_detail": "Emerging AI traffic at 1.1% (~11,689 visits). Top: chatgpt.com (78%), gemini.google.com (5%), claude.ai (3%).",
"geo_concentration": "moderately_concentrated",
"referral_strength": "moderate",
"search_dependency": "moderate",
"consecutive_months": 3,
"engagement_quality": "moderate",
"brand_keyword_ratio": "3/5",
"website_description": "Sizi Novartis ve hastalar, aileler ve toplulukları üzerindeki etkimiz hakkında daha fazla bilgi edinmeye davet ediyoruz. Novartis, dünyanın her yerinde hastaların dönüşen ihtiyaçlarına çözümler üreten İsviçre merkezli global bir sağlık firmasıdır.",
"country_rank_country": "US",
"digital_health_label": "good",
"digital_health_score": 64,
"social_traffic_level": "high",
"brand_strength_detail": "Moderate brand recognition with 30% direct traffic. Brand keyword ratio: 3/5.",
"digital_health_detail": "Score 64: Engagement 43/100 (25%), Volume 100/100 (20%), Brand 60/100 (15%), Diversification 80/100 (15%), Rank 75/100 (15%), AI Readiness 11/100 (10%).",
"social_traffic_detail": "High social traffic at 17% of total visits (~171,578 visits).",
"engagement_quality_score": 43,
"geo_concentration_detail": "Moderately concentrated traffic: US (35%), IN (9%), JP (8%).",
"referral_strength_detail": "Moderate referral strength at 12% of traffic (~125,619 visits).",
"search_dependency_detail": "Moderate search dependency at 37% of total traffic.",
"engagement_quality_detail": "Moderate engagement (43/100) with 50% bounce rate, 2.9 pages per visit, and 88-second average duration."
}
}
curl https://signals.autobound.ai/v1/signals/83261b88-9998-4cd9-8cfa-6b404ebc1f45 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"novartis.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.